Wave Life Sciences Ltd.

WVE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$5.74+4.17%

2026-08-03

Financials

Valuation Metrics

Wave Life Sciences Ltd.'s Market Cap is $1.10B. At end of 2025 it was $3.06B. Ranked #2450 of 3,112 in US market (top 79%), #995 of 1,445 on NASDAQ (top 69%), #185 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 69%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$1.10B	US#2,450/3,112 Sec#185/269
Revenue	$65M	US#2,843/3,112 Sec#149/269
Net Income	$-202M	US—/3,112 Sec—/269
Total Assets	$565M	US#2,699/3,112 Sec#141/269
Net Assets	$454M	US#2,324/3,112 Sec#121/269
Value
P/B	2.44x	US#1,442/3,112 Sec#67/269
P/S	16.89x	US#2,782/3,112 Sec#142/269
FCF Yield	-16.86%	US—/3,112 Sec—/269
Profitability
ROE	-44.64%	US#2,715/3,112 Sec#163/269
ROA	-35.85%	US#2,909/3,112 Sec#180/269
Op. Margin	-333.36%	US#2,882/3,112 Sec#154/269
Revenue Growth	-73.88%	US#2,909/3,112 Sec#172/269
Financial Health
Debt Ratio	24.53%	US#266/3,112 Sec#88/269
Total Debt	$44M	US#2,572/3,112 Sec#153/269
FCF	$-186M	US#2,722/3,112 Sec#213/269
Cash	$368M	US#1,289/3,112 Sec#69/269
Current Ratio	7.13x	US#332/3,112 Sec#107/269
Performance
1Y Return	-33.49%	US#2,815/3,112 Sec#233/269
1M Return	-8.31%	US#2,502/3,112 Sec#150/269
From 52W High	-73.58%	US#3,049/3,112 Sec#258/269
1Y MDD	-74.14%	US#2,982/3,112 Sec#250/269
Trading
Volume	3,367,314 shares	US#563/3,112 Sec#44/269
Trading Value	$19M	US#1,993/3,112 Sec#150/269
Per Share
EPS	$-1.13	US—/3,112 Sec—/269
BPS	$2.92	US#2,426/3,112 Sec#161/269